PubRank

David B Seligson

Author PubWeight™ 34.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer 2007 2.38
2 Smoking negatively impacts renal cell carcinoma overall and cancer-specific survival. Cancer 2011 1.64
3 Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma. Clin Cancer Res 2007 1.61
4 Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol 2010 1.57
5 Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res 2007 1.54
6 CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis. J Urol 2009 1.54
7 Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. J Urol 2004 1.47
8 Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. J Urol 2010 1.43
9 Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci U S A 2002 1.40
10 Histone acetylation regulates intracellular pH. Mol Cell 2012 1.30
11 Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples. Clin Cancer Res 2008 1.25
12 Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy. Cancer Epidemiol Biomarkers Prev 2009 1.23
13 Statistical methods for analyzing tissue microarray data. J Biopharm Stat 2004 1.23
14 Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome. Cancer 2006 1.18
15 Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma. Clin Cancer Res 2009 1.16
16 Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate 2003 1.13
17 Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker. Cancer 2009 1.11
18 Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer 2003 1.10
19 Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer 2005 1.02
20 The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. J Urol 2007 1.01
21 Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score. BJU Int 2006 0.95
22 Elevated MED28 expression predicts poor outcome in women with breast cancer. BMC Cancer 2010 0.94
23 Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. Eur Urol 2012 0.91
24 Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development. Cancer 2010 0.90
25 Expression of arginase II in prostate cancer. Int J Oncol 2008 0.90
26 Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome. Cancer Biomark 2009 0.89
27 Tissue microarrays in the study of non-neoplastic disease of the nervous system. J Neuropathol Exp Neurol 2002 0.86
28 Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. J Urol 2010 0.85
29 Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development. Mod Pathol 2012 0.76